Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q1 2025 Earnings

26FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.06

-0.77

-0.47

-0.18

Details

Expected EPS

-0.486193

Actual EPS

-0.93

Surprise EPS

-0.44

Surprise Percent

+91.28%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -0.93 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.